Vestal Point Capital, LP 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:14 pm Purchase |
2025-03-31 | 13G | Dianthus Therapeutics, Inc. DNTH |
Vestal Point Capital, LP | 1,700,069 5.300% |
1,700,069 (New Position) |
Filing |